Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma
Clinical trial NCT00012064 · COMPLETED
Trial details
- NCT number
- NCT00012064
- Sponsor
- Lisata Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
- Primary completion
- 2011-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.